Stock PROK PROKIDNEY CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus ProKidney Corp.

Equities

PROK

KYG7S53R1049

End-of-day quote Nasdaq
Other stock markets
 06:00:00 2024-05-27 pm EDT 		5-day change 1st Jan Change
3.71 USD +10.09% Intraday chart for ProKidney Corp. +10.09% +108.43%
May. 28 Transcript : ProKidney Corp. - Special Call
May. 10 ProKidney Q1 Loss Unchanged From Year Earlier MT

Evolution of the average Target Price on ProKidney Corp.

Price target over the last 5 years

History of analyst recommendation changes

c4c4a4711c639ab03d20b792095a8af.3jfG4BgCRZ6TYqEcy7vh-V1001gXGL6cZnzMqIXgGaU.tlOLgSxOcavAGO1Vhu2DiBQQ4DpZfIjuXgWF0rSYbM26Y7zZeXUH16oo6A~36a1d7b9a2cdf70e381c5a228ef12f8d

Analyst Recommendations on ProKidney Corp.

BofA Securities Downgrades ProKidney to Neutral From Buy, Cuts Price Target to $2 From $8 MT
BTIG Initiates ProKidney With Buy Rating, $16 Price Target MT
Jefferies Initiates ProKidney With Buy Rating, Price Target is $15 MT
Morgan Stanley Starts ProKidney at Equalweight With $13 Price Target MT
UBS Initiates Coverage on ProKidney With Buy Rating, $18 Price Target MT
Citigroup Starts ProKidney at Buy With $16 Price Target MT
BofA Securities Starts ProKidney at Buy With $14 Price Target MT
Evercore ISI Initiates Coverage on ProKidney With Outperform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
3.48 USD
Average target price
6.333 USD
Spread / Average Target
+81.99%
High Price Target
15 USD
Spread / Highest target
+331.03%
Low Price Target
3 USD
Spread / Lowest Target
-13.79%

Consensus detail

Consensus revision (last 18 months)

Analysts covering ProKidney Corp.

BofA Securities
BTIG
Jefferies & Co.
Morgan Stanley
UBS
Citigroup
Evercore ISI

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. PROK Stock
  4. Consensus ProKidney Corp.